KIP Infrastructure
2.23.2 - ci-build
KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.23.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions
| Active as of 2022-06-14 |
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- <http://hl7.org/fhir/CodeSystem/ATC> a fhir:CodeSystem ; fhir:nodeRole fhir:treeRoot ; fhir:Resource.id [ fhir:value "ATC"] ; fhir:DomainResource.text [ fhir:Narrative.status [ fhir:value "generated" ] ; fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem ATC</b></p><a name=\"ATC\"> </a><a name=\"hcATC\"> </a><p><b>Properties</b></p><p><b>This code system defines the following properties for its concepts</b></p><table class=\"grid\"><tr><td><b>Name</b></td><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td><td><b>Description</b></td></tr><tr><td>comment</td><td>comment</td><td>http://hl7.org/fhir/concept-properties#comment</td><td>string</td><td>A string that provides additional detail pertinent to the use or understanding of the concept</td></tr><tr><td>effectiveDate</td><td>effectiveDate</td><td>http://hl7.org/fhir/concept-properties#effectiveDate</td><td>dateTime</td><td>The date at which the concept status was last changed</td></tr><tr><td>status</td><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>code</td><td>A code that indicates the status of the concept. Typical values are active, experimental, deprecated, and retired</td></tr><tr><td>Inactive</td><td>inactive</td><td>http://hl7.org/fhir/concept-properties#inactive</td><td>boolean</td><td>True if the concept is not considered active - e.g. not a valid concept any more. Property type is boolean, default value is false. Note that the status property may also be used to indicate that a concept is inactive</td></tr></table><p><b>Concepts</b></p><p>This case-sensitive code system <code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code> provides <b>a fragment</b> that includes following codes in an undefined hierarchy:</p><table class=\"codes\"><tr><td><b>Lvl</b></td><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td>1</td><td style=\"white-space:nowrap\">B01A<a name=\"ATC-B01A\"> </a></td><td>ANTITHROMBOTIC AGENTS</td><td>B01A - ANTITHROMBOTIC AGENTS</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AA03<a name=\"ATC-B01AA03\"> </a></td><td>warfarin</td><td>B01AA03 - warfarin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AB01<a name=\"ATC-B01AB01\"> </a></td><td>heparin</td><td>B01AB01 - heparin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AB04<a name=\"ATC-B01AB04\"> </a></td><td>dalteparin</td><td>B01AB04 - dalteparin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AB05<a name=\"ATC-B01AB05\"> </a></td><td>enoxaparin</td><td>B01AB05 - enoxaparin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AB10<a name=\"ATC-B01AB10\"> </a></td><td>tinzaparin</td><td>B01AB10 - tinzaparin</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AC06<a name=\"ATC-B01AC06\"> </a></td><td>acetylsalicylic acid</td><td>B01AC06 - acetylsalicylic acid</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AE07<a name=\"ATC-B01AE07\"> </a></td><td>dabigatran etexilate</td><td>B01AE07 - dabigatran etexilate</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AF01<a name=\"ATC-B01AF01\"> </a></td><td>rivaroxaban</td><td>B01AF01 - rivaroxaban</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AF02<a name=\"ATC-B01AF02\"> </a></td><td>apixaban</td><td>B01AF02 - apixaban</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> B01AX05<a name=\"ATC-B01AX05\"> </a></td><td>fondaparinux</td><td>B01AX05 - fondaparinux</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">B02AA02<a name=\"ATC-B02AA02\"> </a></td><td>tranexamic acid</td><td>B02AA02 - Tranexamic acid</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">B03XA01<a name=\"ATC-B03XA01\"> </a></td><td>erythropoietin</td><td>B03XA01 - erythropoietin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">C10AA<a name=\"ATC-C10AA\"> </a></td><td>HMG CoA reductase inhibitors</td><td>C10AA - HMG CoA reductase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">H02<a name=\"ATC-H02\"> </a></td><td>CORTICOSTEROIDS FOR SYSTEMIC USE</td><td>H02 - CORTICOSTEROIDS FOR SYSTEMIC USE</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01CF01<a name=\"ATC-J01CF01\"> </a></td><td>dicloxacillin</td><td>J01CF01 - dicloxacillin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01CF02<a name=\"ATC-J01CF02\"> </a></td><td>cloxacillin</td><td>J01CF02 - cloxacillin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01CF03<a name=\"ATC-J01CF03\"> </a></td><td>meticillin</td><td>J01CF03 - meticillin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01CF05<a name=\"ATC-J01CF05\"> </a></td><td>flucloxacillin</td><td>J01CF05 - flucloxacillin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01DB01<a name=\"ATC-J01DB01\"> </a></td><td>cefalexin</td><td>J01DB01 - cefalexin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01DB03<a name=\"ATC-J01DB03\"> </a></td><td>cefalotin</td><td>J01DB03 - cefalotin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01DC02<a name=\"ATC-J01DC02\"> </a></td><td>cefuroxime</td><td>J01DC02 - cefuroxime</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01FA01<a name=\"ATC-J01FA01\"> </a></td><td>erythromycin</td><td>J01FA01 - erythromycin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01GB03<a name=\"ATC-J01GB03\"> </a></td><td>gentamicin</td><td>J01GB03 - gentamicin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">J01XA01<a name=\"ATC-J01XA01\"> </a></td><td>vancomycin</td><td>J01XA01 - vancomycin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA01<a name=\"ATC-L01AA01\"> </a></td><td>cyclophosphamide</td><td>L01AA01 - cyclophosphamide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA02<a name=\"ATC-L01AA02\"> </a></td><td>chlorambucil</td><td>L01AA02 - chlorambucil</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA03<a name=\"ATC-L01AA03\"> </a></td><td>melphalan</td><td>L01AA03 - melphalan</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA06<a name=\"ATC-L01AA06\"> </a></td><td>ifosfamide</td><td>L01AA06 - ifosfamide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AA09<a name=\"ATC-L01AA09\"> </a></td><td>bendamustine</td><td>L01AA09 - bendamustine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AB01<a name=\"ATC-L01AB01\"> </a></td><td>busulfan</td><td>L01AB01 - busulfan</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AC01<a name=\"ATC-L01AC01\"> </a></td><td>thiotepa</td><td>L01AC01 thiotepa</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AD01<a name=\"ATC-L01AD01\"> </a></td><td>carmustine</td><td>L01AD01 - carmustine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AX03<a name=\"ATC-L01AX03\"> </a></td><td>temozolomide</td><td>L01AX03 - temozolomide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01AX04<a name=\"ATC-L01AX04\"> </a></td><td>dacarbazine</td><td>L01AX04 - dacarbazine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BB05<a name=\"ATC-L01BB05\"> </a></td><td>fludarabine</td><td>L01BB05 - fludarabine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BC02<a name=\"ATC-L01BC02\"> </a></td><td>fluorouracil</td><td>L01BC02 - Fluorouracil (5-FU)</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BC05<a name=\"ATC-L01BC05\"> </a></td><td>gemcitabine</td><td>L01BC02 - Gemcitabine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BC06<a name=\"ATC-L01BC06\"> </a></td><td>capecitabine</td><td>L01BC06 - Capecitabine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01BC07<a name=\"ATC-L01BC07\"> </a></td><td>azacitidine</td><td>L01BC07 - azacitidine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CA02<a name=\"ATC-L01CA02\"> </a></td><td>vincristine</td><td>L01CA02 - vincristine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CA04<a name=\"ATC-L01CA04\"> </a></td><td>vinorelbine</td><td>L01CA04 - Vinorelbine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CB01<a name=\"ATC-L01CB01\"> </a></td><td>etoposide</td><td>L01CB01 - etoposide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CD01<a name=\"ATC-L01CD01\"> </a></td><td>paclitaxel</td><td>L01CD01 - Paclitaxel</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CD02<a name=\"ATC-L01CD02\"> </a></td><td>docetaxel</td><td>L01CD02 - Docetaxel</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01CE02<a name=\"ATC-L01CE02\"> </a></td><td>irinotecan</td><td>L01CE02 - Irinotecan</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DB01<a name=\"ATC-L01DB01\"> </a></td><td>doxorubicin</td><td>L01DB01 - Doxorubicin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DB03<a name=\"ATC-L01DB03\"> </a></td><td>epirubicin</td><td>L01DB03 - Epirubicin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DB07<a name=\"ATC-L01DB07\"> </a></td><td>mitoxantrone</td><td>L01DB07 - mitoxantrone</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DB11<a name=\"ATC-L01DB11\"> </a></td><td>pixantrone</td><td>L01DB11 - pixantrone</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01DC01<a name=\"ATC-L01DC01\"> </a></td><td>bleomycin</td><td>L01DC01 - bleomycin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EA<a name=\"ATC-L01EA\"> </a></td><td>BCR-ABL tyrosine kinase inhibitors</td><td/></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01EA01<a name=\"ATC-L01EA01\"> </a></td><td>imatinib</td><td>L01EA01 - imatinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01EA02<a name=\"ATC-L01EA02\"> </a></td><td>dasatinib</td><td>L01EA02 - dasatinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01EA03<a name=\"ATC-L01EA03\"> </a></td><td>nilotinib</td><td>L01EA03 - nilotinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01EA04<a name=\"ATC-L01EA04\"> </a></td><td>bosutinib</td><td>L01EA04 - bosutinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01EA05<a name=\"ATC-L01EA05\"> </a></td><td>ponatinib</td><td>L01EA05 - ponatinib</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01EA06<a name=\"ATC-L01EA06\"> </a></td><td>Asciminib</td><td>L01EA06 - Asciminib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EB<a name=\"ATC-L01EB\"> </a></td><td>Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors</td><td>L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EH<a name=\"ATC-L01EH\"> </a></td><td>Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors</td><td>L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EJ<a name=\"ATC-L01EJ\"> </a></td><td>Janus-associated kinase (JAK) inhibitors</td><td>Janus associerede kinase (JAK) hæmmere</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01EJ01<a name=\"ATC-L01EJ01\"> </a></td><td>ruxolitinib</td><td>L01EJ01 - ruxolitinib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EK<a name=\"ATC-L01EK\"> </a></td><td>Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors</td><td>L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EL01<a name=\"ATC-L01EL01\"> </a></td><td>ibrutinib</td><td>L01EL01 - ibrutinib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EL02<a name=\"ATC-L01EL02\"> </a></td><td>acalabrutinib</td><td>L01EL02 - acalabrutinib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EM01<a name=\"ATC-L01EM01\"> </a></td><td>idelalisib</td><td>L01EM01 - idelalisib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01EN<a name=\"ATC-L01EN\"> </a></td><td>Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors</td><td>L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FA01<a name=\"ATC-L01FA01\"> </a></td><td>rituximab</td><td>L01FA01 - rituximab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FA02<a name=\"ATC-L01FA02\"> </a></td><td>ofatumumab</td><td>L01FA02 - ofatumumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FA03<a name=\"ATC-L01FA03\"> </a></td><td>obinutuzumab</td><td>L01FA03 - obinutuzumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FC01<a name=\"ATC-L01FC01\"> </a></td><td>daratumumab</td><td>L01FC01 - daratumumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FC02<a name=\"ATC-L01FC02\"> </a></td><td>isatuximab</td><td>L01FC02 - isatuximab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FD01<a name=\"ATC-L01FD01\"> </a></td><td>trastuzumab</td><td>L01FD01 - Trastuzumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FF<a name=\"ATC-L01FF\"> </a></td><td>PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors</td><td>L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01FF01<a name=\"ATC-L01FF01\"> </a></td><td>nivolumab</td><td>L01FF01 - Nivolumab</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01FF02<a name=\"ATC-L01FF02\"> </a></td><td>pembrolizumab</td><td>L01FF02 - Pembrolizumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FG01<a name=\"ATC-L01FG01\"> </a></td><td>bevacizumab</td><td>L01FG01 - Bevacizumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FX05<a name=\"ATC-L01FX05\"> </a></td><td>brentuximab vedotin</td><td>L01FX05 - brentuximab vedotin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FX08<a name=\"ATC-L01FX08\"> </a></td><td>elotuzumab</td><td>L01FX08 - elotuzumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01FX14<a name=\"ATC-L01FX14\"> </a></td><td>polatuzumab vedotin</td><td>L01FX14 - polatuzumab vedotin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XA01<a name=\"ATC-L01XA01\"> </a></td><td>cisplatin</td><td>L01XA01 - Cisplatin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XA02<a name=\"ATC-L01XA02\"> </a></td><td>carboplatin</td><td>L01XA02 - Carboplatin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XA03<a name=\"ATC-L01XA03\"> </a></td><td>oxaliplatin</td><td>L01XA03 - Oxaliplatin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XG01<a name=\"ATC-L01XG01\"> </a></td><td>bortezomib</td><td>L01XG01 - bortezomib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XG02<a name=\"ATC-L01XG02\"> </a></td><td>carfilzomib</td><td>L01XG02 - carfilzomib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XG03<a name=\"ATC-L01XG03\"> </a></td><td>ixazomib</td><td>L01XG03 - ixazomib</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XH<a name=\"ATC-L01XH\"> </a></td><td>Histone deacetylase (HDAC) inhibitors</td><td>L01XH - Histone deacetylase (HDAC) inhibitors</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01XH01<a name=\"ATC-L01XH01\"> </a></td><td>vorinostat</td><td>L01XH01 - vorinostat</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L01XH03<a name=\"ATC-L01XH03\"> </a></td><td>panobinostat</td><td>L01XH03 - panobinostat</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XX05<a name=\"ATC-L01XX05\"> </a></td><td>hydroxycarbamide</td><td>L01XX05 - hydroxycarbamide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XX35<a name=\"ATC-L01XX35\"> </a></td><td>anagrelide</td><td>L01XX35 - anagrelide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L01XX52<a name=\"ATC-L01XX52\"> </a></td><td>venetoclax</td><td>L01XX52 - venetoclax</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L03AB<a name=\"ATC-L03AB\"> </a></td><td>Interferons</td><td>L03AB - Interferons</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04A<a name=\"ATC-L04A\"> </a></td><td>IMMUNOSUPPRESSANTS</td><td>L04A - IMMUNOSUPPRESSANTS</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> L04AA<a name=\"ATC-L04AA\"> </a></td><td>Selective immunosuppressants</td><td>L04AA - Selective immunosuppressants</td></tr><tr><td>3</td><td style=\"white-space:nowrap\"> L04AA34<a name=\"ATC-L04AA34\"> </a></td><td>alemtuzumab</td><td>L04AA34 - alemtuzumab</td></tr><tr><td>3</td><td style=\"white-space:nowrap\"> L04AA40<a name=\"ATC-L04AA40\"> </a></td><td>cladribine</td><td>L04AA40 - cladribine</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04AD01<a name=\"ATC-L04AD01\"> </a></td><td>ciclosporin</td><td>L04AD01 - ciclosporin</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04AX02<a name=\"ATC-L04AX02\"> </a></td><td>thalidomide</td><td>L04AX02 - thalidomide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04AX04<a name=\"ATC-L04AX04\"> </a></td><td>lenalidomide</td><td>L04AX04 - lenalidomide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">L04AX06<a name=\"ATC-L04AX06\"> </a></td><td>pomalidomide</td><td>L04AX06 - pomalidomide</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">M05BA03<a name=\"ATC-M05BA03\"> </a></td><td>pamidronic acid</td><td>M05BA03 - pamidronic acid</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">M05BA08<a name=\"ATC-M05BA08\"> </a></td><td>zoledronic acid</td><td>M05BA08 - zoledronic acid</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">M05BX04<a name=\"ATC-M05BX04\"> </a></td><td>denosumab</td><td>M05BX04 - denosumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">S01LA08<a name=\"ATC-S01LA08\"> </a></td><td>bevacizumab</td><td>S01LA08 - Bevacizumab</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">V10X<a name=\"ATC-V10X\"> </a></td><td>OTHER THERAPEUTIC RADIOPHARMACEUTICALS</td><td>V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> V10XA53<a name=\"ATC-V10XA53\"> </a></td><td>tositumomab/iodine (131I) tositumomab</td><td>V10XA53 - tositumomab/iodine (131I) tositumomab</td></tr><tr><td>2</td><td style=\"white-space:nowrap\"> V10XX02<a name=\"ATC-V10XX02\"> </a></td><td>ibritumomab tiuxetan (90Y)</td><td>V10XX02 - ibritumomab tiuxetan (90Y)</td></tr></table></div>" ] ; fhir:CodeSystem.url [ fhir:value "https://kip.rkkp.dk/fhir/CodeSystem/ATC"] ; fhir:CodeSystem.identifier [ fhir:index 0 ; fhir:Identifier.value [ fhir:value "urn:oid:2.16.840.1.113883.6.73" ] ] ; fhir:CodeSystem.version [ fhir:value "2.23.2"] ; fhir:CodeSystem.name [ fhir:value "ATC"] ; fhir:CodeSystem.title [ fhir:value "WHO ATC"] ; fhir:CodeSystem.status [ fhir:value "active"] ; fhir:CodeSystem.date [ fhir:value "2022-06-14T00:00:00+02:00"^^xsd:dateTime] ; fhir:CodeSystem.publisher [ fhir:value "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"] ; fhir:CodeSystem.contact [ fhir:index 0 ; fhir:ContactDetail.name [ fhir:value "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S" ] ; fhir:ContactDetail.telecom [ fhir:index 0 ; fhir:ContactPoint.system [ fhir:value "url" ] ; fhir:ContactPoint.value [ fhir:value "https://trifork.com" ] ], [ fhir:index 1 ; fhir:ContactPoint.system [ fhir:value "email" ] ; fhir:ContactPoint.value [ fhir:value "rbk@trifork.com" ] ] ] ; fhir:CodeSystem.description [ fhir:value "WHO ATC code system. Link: http://www.whocc.no/atc"] ; fhir:CodeSystem.caseSensitive [ fhir:value "true"^^xsd:boolean] ; fhir:CodeSystem.content [ fhir:value "fragment"] ; fhir:CodeSystem.property [ fhir:index 0 ; fhir:CodeSystem.property.code [ fhir:value "comment" ] ; fhir:CodeSystem.property.uri [ fhir:value "http://hl7.org/fhir/concept-properties#comment" ] ; fhir:CodeSystem.property.description [ fhir:value "A string that provides additional detail pertinent to the use or understanding of the concept" ] ; fhir:CodeSystem.property.type [ fhir:value "string" ] ], [ fhir:index 1 ; fhir:CodeSystem.property.code [ fhir:value "effectiveDate" ] ; fhir:CodeSystem.property.uri [ fhir:value "http://hl7.org/fhir/concept-properties#effectiveDate" ] ; fhir:CodeSystem.property.description [ fhir:value "The date at which the concept status was last changed" ] ; fhir:CodeSystem.property.type [ fhir:value "dateTime" ] ], [ fhir:index 2 ; fhir:CodeSystem.property.code [ fhir:value "status" ] ; fhir:CodeSystem.property.uri [ fhir:value "http://hl7.org/fhir/concept-properties#status" ] ; fhir:CodeSystem.property.description [ fhir:value "A code that indicates the status of the concept. Typical values are active, experimental, deprecated, and retired" ] ; fhir:CodeSystem.property.type [ fhir:value "code" ] ], [ fhir:index 3 ; fhir:CodeSystem.property.code [ fhir:value "inactive" ] ; fhir:CodeSystem.property.uri [ fhir:value "http://hl7.org/fhir/concept-properties#inactive" ] ; fhir:CodeSystem.property.description [ fhir:value "True if the concept is not considered active - e.g. not a valid concept any more. Property type is boolean, default value is false. Note that the status property may also be used to indicate that a concept is inactive" ] ; fhir:CodeSystem.property.type [ fhir:value "boolean" ] ] ; fhir:CodeSystem.concept [ fhir:index 0 ; fhir:CodeSystem.concept.code [ fhir:value "B01A" ] ; fhir:CodeSystem.concept.display [ fhir:value "ANTITHROMBOTIC AGENTS" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01A - ANTITHROMBOTIC AGENTS" ] ; fhir:CodeSystem.concept.concept [ fhir:index 0 ; fhir:CodeSystem.concept.code [ fhir:value "B01AA03" ] ; fhir:CodeSystem.concept.display [ fhir:value "warfarin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AA03 - warfarin" ] ], [ fhir:index 1 ; fhir:CodeSystem.concept.code [ fhir:value "B01AB01" ] ; fhir:CodeSystem.concept.display [ fhir:value "heparin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AB01 - heparin" ] ], [ fhir:index 2 ; fhir:CodeSystem.concept.code [ fhir:value "B01AB04" ] ; fhir:CodeSystem.concept.display [ fhir:value "dalteparin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AB04 - dalteparin" ] ], [ fhir:index 3 ; fhir:CodeSystem.concept.code [ fhir:value "B01AB05" ] ; fhir:CodeSystem.concept.display [ fhir:value "enoxaparin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AB05 - enoxaparin" ] ], [ fhir:index 4 ; fhir:CodeSystem.concept.code [ fhir:value "B01AB10" ] ; fhir:CodeSystem.concept.display [ fhir:value "tinzaparin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AB10 - tinzaparin" ] ], [ fhir:index 5 ; fhir:CodeSystem.concept.code [ fhir:value "B01AC06" ] ; fhir:CodeSystem.concept.display [ fhir:value "acetylsalicylic acid" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AC06 - acetylsalicylic acid" ] ], [ fhir:index 6 ; fhir:CodeSystem.concept.code [ fhir:value "B01AE07" ] ; fhir:CodeSystem.concept.display [ fhir:value "dabigatran etexilate" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AE07 - dabigatran etexilate" ] ], [ fhir:index 7 ; fhir:CodeSystem.concept.code [ fhir:value "B01AF01" ] ; fhir:CodeSystem.concept.display [ fhir:value "rivaroxaban" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AF01 - rivaroxaban" ] ], [ fhir:index 8 ; fhir:CodeSystem.concept.code [ fhir:value "B01AF02" ] ; fhir:CodeSystem.concept.display [ fhir:value "apixaban" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AF02 - apixaban" ] ], [ fhir:index 9 ; fhir:CodeSystem.concept.code [ fhir:value "B01AX05" ] ; fhir:CodeSystem.concept.display [ fhir:value "fondaparinux" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B01AX05 - fondaparinux" ] ] ], [ fhir:index 1 ; fhir:CodeSystem.concept.code [ fhir:value "B02AA02" ] ; fhir:CodeSystem.concept.display [ fhir:value "tranexamic acid" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B02AA02 - Tranexamic acid" ] ], [ fhir:index 2 ; fhir:CodeSystem.concept.code [ fhir:value "B03XA01" ] ; fhir:CodeSystem.concept.display [ fhir:value "erythropoietin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "B03XA01 - erythropoietin" ] ], [ fhir:index 3 ; fhir:CodeSystem.concept.code [ fhir:value "C10AA" ] ; fhir:CodeSystem.concept.display [ fhir:value "HMG CoA reductase inhibitors" ] ; fhir:CodeSystem.concept.definition [ fhir:value "C10AA - HMG CoA reductase inhibitors" ] ], [ fhir:index 4 ; fhir:CodeSystem.concept.code [ fhir:value "H02" ] ; fhir:CodeSystem.concept.display [ fhir:value "CORTICOSTEROIDS FOR SYSTEMIC USE" ] ; fhir:CodeSystem.concept.definition [ fhir:value "H02 - CORTICOSTEROIDS FOR SYSTEMIC USE" ] ], [ fhir:index 5 ; fhir:CodeSystem.concept.code [ fhir:value "J01CF01" ] ; fhir:CodeSystem.concept.display [ fhir:value "dicloxacillin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01CF01 - dicloxacillin" ] ], [ fhir:index 6 ; fhir:CodeSystem.concept.code [ fhir:value "J01CF02" ] ; fhir:CodeSystem.concept.display [ fhir:value "cloxacillin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01CF02 - cloxacillin" ] ], [ fhir:index 7 ; fhir:CodeSystem.concept.code [ fhir:value "J01CF03" ] ; fhir:CodeSystem.concept.display [ fhir:value "meticillin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01CF03 - meticillin" ] ], [ fhir:index 8 ; fhir:CodeSystem.concept.code [ fhir:value "J01CF05" ] ; fhir:CodeSystem.concept.display [ fhir:value "flucloxacillin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01CF05 - flucloxacillin" ] ], [ fhir:index 9 ; fhir:CodeSystem.concept.code [ fhir:value "J01DB01" ] ; fhir:CodeSystem.concept.display [ fhir:value "cefalexin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01DB01 - cefalexin" ] ], [ fhir:index 10 ; fhir:CodeSystem.concept.code [ fhir:value "J01DB03" ] ; fhir:CodeSystem.concept.display [ fhir:value "cefalotin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01DB03 - cefalotin" ] ], [ fhir:index 11 ; fhir:CodeSystem.concept.code [ fhir:value "J01DC02" ] ; fhir:CodeSystem.concept.display [ fhir:value "cefuroxime" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01DC02 - cefuroxime" ] ], [ fhir:index 12 ; fhir:CodeSystem.concept.code [ fhir:value "J01FA01" ] ; fhir:CodeSystem.concept.display [ fhir:value "erythromycin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01FA01 - erythromycin" ] ], [ fhir:index 13 ; fhir:CodeSystem.concept.code [ fhir:value "J01GB03" ] ; fhir:CodeSystem.concept.display [ fhir:value "gentamicin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01GB03 - gentamicin" ] ], [ fhir:index 14 ; fhir:CodeSystem.concept.code [ fhir:value "J01XA01" ] ; fhir:CodeSystem.concept.display [ fhir:value "vancomycin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "J01XA01 - vancomycin" ] ], [ fhir:index 15 ; fhir:CodeSystem.concept.code [ fhir:value "L01AA01" ] ; fhir:CodeSystem.concept.display [ fhir:value "cyclophosphamide" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AA01 - cyclophosphamide" ] ], [ fhir:index 16 ; fhir:CodeSystem.concept.code [ fhir:value "L01AA02" ] ; fhir:CodeSystem.concept.display [ fhir:value "chlorambucil" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AA02 - chlorambucil" ] ], [ fhir:index 17 ; fhir:CodeSystem.concept.code [ fhir:value "L01AA03" ] ; fhir:CodeSystem.concept.display [ fhir:value "melphalan" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AA03 - melphalan" ] ], [ fhir:index 18 ; fhir:CodeSystem.concept.code [ fhir:value "L01AA06" ] ; fhir:CodeSystem.concept.display [ fhir:value "ifosfamide" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AA06 - ifosfamide" ] ], [ fhir:index 19 ; fhir:CodeSystem.concept.code [ fhir:value "L01AA09" ] ; fhir:CodeSystem.concept.display [ fhir:value "bendamustine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AA09 - bendamustine" ] ], [ fhir:index 20 ; fhir:CodeSystem.concept.code [ fhir:value "L01AB01" ] ; fhir:CodeSystem.concept.display [ fhir:value "busulfan" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AB01 - busulfan" ] ], [ fhir:index 21 ; fhir:CodeSystem.concept.code [ fhir:value "L01AC01" ] ; fhir:CodeSystem.concept.display [ fhir:value "thiotepa" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AC01 thiotepa" ] ], [ fhir:index 22 ; fhir:CodeSystem.concept.code [ fhir:value "L01AD01" ] ; fhir:CodeSystem.concept.display [ fhir:value "carmustine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AD01 - carmustine" ] ], [ fhir:index 23 ; fhir:CodeSystem.concept.code [ fhir:value "L01AX03" ] ; fhir:CodeSystem.concept.display [ fhir:value "temozolomide" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AX03 - temozolomide" ] ], [ fhir:index 24 ; fhir:CodeSystem.concept.code [ fhir:value "L01AX04" ] ; fhir:CodeSystem.concept.display [ fhir:value "dacarbazine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01AX04 - dacarbazine" ] ], [ fhir:index 25 ; fhir:CodeSystem.concept.code [ fhir:value "L01BB05" ] ; fhir:CodeSystem.concept.display [ fhir:value "fludarabine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01BB05 - fludarabine" ] ], [ fhir:index 26 ; fhir:CodeSystem.concept.code [ fhir:value "L01BC02" ] ; fhir:CodeSystem.concept.display [ fhir:value "fluorouracil" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01BC02 - Fluorouracil (5-FU)" ] ], [ fhir:index 27 ; fhir:CodeSystem.concept.code [ fhir:value "L01BC05" ] ; fhir:CodeSystem.concept.display [ fhir:value "gemcitabine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01BC02 - Gemcitabine" ] ], [ fhir:index 28 ; fhir:CodeSystem.concept.code [ fhir:value "L01BC06" ] ; fhir:CodeSystem.concept.display [ fhir:value "capecitabine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01BC06 - Capecitabine" ] ], [ fhir:index 29 ; fhir:CodeSystem.concept.code [ fhir:value "L01BC07" ] ; fhir:CodeSystem.concept.display [ fhir:value "azacitidine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01BC07 - azacitidine" ] ], [ fhir:index 30 ; fhir:CodeSystem.concept.code [ fhir:value "L01CA02" ] ; fhir:CodeSystem.concept.display [ fhir:value "vincristine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01CA02 - vincristine" ] ], [ fhir:index 31 ; fhir:CodeSystem.concept.code [ fhir:value "L01CA04" ] ; fhir:CodeSystem.concept.display [ fhir:value "vinorelbine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01CA04 - Vinorelbine" ] ], [ fhir:index 32 ; fhir:CodeSystem.concept.code [ fhir:value "L01CB01" ] ; fhir:CodeSystem.concept.display [ fhir:value "etoposide" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01CB01 - etoposide" ] ], [ fhir:index 33 ; fhir:CodeSystem.concept.code [ fhir:value "L01CD01" ] ; fhir:CodeSystem.concept.display [ fhir:value "paclitaxel" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01CD01 - Paclitaxel" ] ], [ fhir:index 34 ; fhir:CodeSystem.concept.code [ fhir:value "L01CD02" ] ; fhir:CodeSystem.concept.display [ fhir:value "docetaxel" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01CD02 - Docetaxel" ] ], [ fhir:index 35 ; fhir:CodeSystem.concept.code [ fhir:value "L01CE02" ] ; fhir:CodeSystem.concept.display [ fhir:value "irinotecan" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01CE02 - Irinotecan" ] ], [ fhir:index 36 ; fhir:CodeSystem.concept.code [ fhir:value "L01DB01" ] ; fhir:CodeSystem.concept.display [ fhir:value "doxorubicin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01DB01 - Doxorubicin" ] ], [ fhir:index 37 ; fhir:CodeSystem.concept.code [ fhir:value "L01DB03" ] ; fhir:CodeSystem.concept.display [ fhir:value "epirubicin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01DB03 - Epirubicin" ] ], [ fhir:index 38 ; fhir:CodeSystem.concept.code [ fhir:value "L01DB07" ] ; fhir:CodeSystem.concept.display [ fhir:value "mitoxantrone" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01DB07 - mitoxantrone" ] ], [ fhir:index 39 ; fhir:CodeSystem.concept.code [ fhir:value "L01DB11" ] ; fhir:CodeSystem.concept.display [ fhir:value "pixantrone" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01DB11 - pixantrone" ] ], [ fhir:index 40 ; fhir:CodeSystem.concept.code [ fhir:value "L01DC01" ] ; fhir:CodeSystem.concept.display [ fhir:value "bleomycin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01DC01 - bleomycin" ] ], [ fhir:index 41 ; fhir:CodeSystem.concept.code [ fhir:value "L01EA" ] ; fhir:CodeSystem.concept.display [ fhir:value "BCR-ABL tyrosine kinase inhibitors" ] ; fhir:CodeSystem.concept.concept [ fhir:index 0 ; fhir:CodeSystem.concept.code [ fhir:value "L01EA01" ] ; fhir:CodeSystem.concept.display [ fhir:value "imatinib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EA01 - imatinib" ] ], [ fhir:index 1 ; fhir:CodeSystem.concept.code [ fhir:value "L01EA02" ] ; fhir:CodeSystem.concept.display [ fhir:value "dasatinib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EA02 - dasatinib" ] ], [ fhir:index 2 ; fhir:CodeSystem.concept.code [ fhir:value "L01EA03" ] ; fhir:CodeSystem.concept.display [ fhir:value "nilotinib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EA03 - nilotinib" ] ], [ fhir:index 3 ; fhir:CodeSystem.concept.code [ fhir:value "L01EA04" ] ; fhir:CodeSystem.concept.display [ fhir:value "bosutinib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EA04 - bosutinib" ] ], [ fhir:index 4 ; fhir:CodeSystem.concept.code [ fhir:value "L01EA05" ] ; fhir:CodeSystem.concept.display [ fhir:value "ponatinib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EA05 - ponatinib" ] ], [ fhir:index 5 ; fhir:CodeSystem.concept.code [ fhir:value "L01EA06" ] ; fhir:CodeSystem.concept.display [ fhir:value "Asciminib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EA06 - Asciminib" ] ] ], [ fhir:index 42 ; fhir:CodeSystem.concept.code [ fhir:value "L01EB" ] ; fhir:CodeSystem.concept.display [ fhir:value "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors" ] ], [ fhir:index 43 ; fhir:CodeSystem.concept.code [ fhir:value "L01EH" ] ; fhir:CodeSystem.concept.display [ fhir:value "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors" ] ], [ fhir:index 44 ; fhir:CodeSystem.concept.code [ fhir:value "L01EJ" ] ; fhir:CodeSystem.concept.display [ fhir:value "Janus-associated kinase (JAK) inhibitors" ] ; fhir:CodeSystem.concept.definition [ fhir:value "Janus associerede kinase (JAK) hæmmere" ] ; fhir:CodeSystem.concept.concept [ fhir:index 0 ; fhir:CodeSystem.concept.code [ fhir:value "L01EJ01" ] ; fhir:CodeSystem.concept.display [ fhir:value "ruxolitinib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EJ01 - ruxolitinib" ] ] ], [ fhir:index 45 ; fhir:CodeSystem.concept.code [ fhir:value "L01EK" ] ; fhir:CodeSystem.concept.display [ fhir:value "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors" ] ], [ fhir:index 46 ; fhir:CodeSystem.concept.code [ fhir:value "L01EL01" ] ; fhir:CodeSystem.concept.display [ fhir:value "ibrutinib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EL01 - ibrutinib" ] ], [ fhir:index 47 ; fhir:CodeSystem.concept.code [ fhir:value "L01EL02" ] ; fhir:CodeSystem.concept.display [ fhir:value "acalabrutinib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EL02 - acalabrutinib" ] ], [ fhir:index 48 ; fhir:CodeSystem.concept.code [ fhir:value "L01EM01" ] ; fhir:CodeSystem.concept.display [ fhir:value "idelalisib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EM01 - idelalisib" ] ], [ fhir:index 49 ; fhir:CodeSystem.concept.code [ fhir:value "L01EN" ] ; fhir:CodeSystem.concept.display [ fhir:value "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors" ] ], [ fhir:index 50 ; fhir:CodeSystem.concept.code [ fhir:value "L01FA01" ] ; fhir:CodeSystem.concept.display [ fhir:value "rituximab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FA01 - rituximab" ] ], [ fhir:index 51 ; fhir:CodeSystem.concept.code [ fhir:value "L01FA02" ] ; fhir:CodeSystem.concept.display [ fhir:value "ofatumumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FA02 - ofatumumab" ] ], [ fhir:index 52 ; fhir:CodeSystem.concept.code [ fhir:value "L01FA03" ] ; fhir:CodeSystem.concept.display [ fhir:value "obinutuzumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FA03 - obinutuzumab" ] ], [ fhir:index 53 ; fhir:CodeSystem.concept.code [ fhir:value "L01FC01" ] ; fhir:CodeSystem.concept.display [ fhir:value "daratumumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FC01 - daratumumab" ] ], [ fhir:index 54 ; fhir:CodeSystem.concept.code [ fhir:value "L01FC02" ] ; fhir:CodeSystem.concept.display [ fhir:value "isatuximab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FC02 - isatuximab" ] ], [ fhir:index 55 ; fhir:CodeSystem.concept.code [ fhir:value "L01FD01" ] ; fhir:CodeSystem.concept.display [ fhir:value "trastuzumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FD01 - Trastuzumab" ] ], [ fhir:index 56 ; fhir:CodeSystem.concept.code [ fhir:value "L01FF" ] ; fhir:CodeSystem.concept.display [ fhir:value "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors" ] ; fhir:CodeSystem.concept.concept [ fhir:index 0 ; fhir:CodeSystem.concept.code [ fhir:value "L01FF01" ] ; fhir:CodeSystem.concept.display [ fhir:value "nivolumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FF01 - Nivolumab" ] ], [ fhir:index 1 ; fhir:CodeSystem.concept.code [ fhir:value "L01FF02" ] ; fhir:CodeSystem.concept.display [ fhir:value "pembrolizumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FF02 - Pembrolizumab" ] ] ], [ fhir:index 57 ; fhir:CodeSystem.concept.code [ fhir:value "L01FG01" ] ; fhir:CodeSystem.concept.display [ fhir:value "bevacizumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FG01 - Bevacizumab" ] ], [ fhir:index 58 ; fhir:CodeSystem.concept.code [ fhir:value "L01FX05" ] ; fhir:CodeSystem.concept.display [ fhir:value "brentuximab vedotin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FX05 - brentuximab vedotin" ] ], [ fhir:index 59 ; fhir:CodeSystem.concept.code [ fhir:value "L01FX08" ] ; fhir:CodeSystem.concept.display [ fhir:value "elotuzumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FX08 - elotuzumab" ] ], [ fhir:index 60 ; fhir:CodeSystem.concept.code [ fhir:value "L01FX14" ] ; fhir:CodeSystem.concept.display [ fhir:value "polatuzumab vedotin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01FX14 - polatuzumab vedotin" ] ], [ fhir:index 61 ; fhir:CodeSystem.concept.code [ fhir:value "L01XA01" ] ; fhir:CodeSystem.concept.display [ fhir:value "cisplatin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XA01 - Cisplatin" ] ], [ fhir:index 62 ; fhir:CodeSystem.concept.code [ fhir:value "L01XA02" ] ; fhir:CodeSystem.concept.display [ fhir:value "carboplatin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XA02 - Carboplatin" ] ], [ fhir:index 63 ; fhir:CodeSystem.concept.code [ fhir:value "L01XA03" ] ; fhir:CodeSystem.concept.display [ fhir:value "oxaliplatin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XA03 - Oxaliplatin" ] ], [ fhir:index 64 ; fhir:CodeSystem.concept.code [ fhir:value "L01XG01" ] ; fhir:CodeSystem.concept.display [ fhir:value "bortezomib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XG01 - bortezomib" ] ], [ fhir:index 65 ; fhir:CodeSystem.concept.code [ fhir:value "L01XG02" ] ; fhir:CodeSystem.concept.display [ fhir:value "carfilzomib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XG02 - carfilzomib" ] ], [ fhir:index 66 ; fhir:CodeSystem.concept.code [ fhir:value "L01XG03" ] ; fhir:CodeSystem.concept.display [ fhir:value "ixazomib" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XG03 - ixazomib" ] ], [ fhir:index 67 ; fhir:CodeSystem.concept.code [ fhir:value "L01XH" ] ; fhir:CodeSystem.concept.display [ fhir:value "Histone deacetylase (HDAC) inhibitors" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XH - Histone deacetylase (HDAC) inhibitors" ] ; fhir:CodeSystem.concept.concept [ fhir:index 0 ; fhir:CodeSystem.concept.code [ fhir:value "L01XH01" ] ; fhir:CodeSystem.concept.display [ fhir:value "vorinostat" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XH01 - vorinostat" ] ], [ fhir:index 1 ; fhir:CodeSystem.concept.code [ fhir:value "L01XH03" ] ; fhir:CodeSystem.concept.display [ fhir:value "panobinostat" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XH03 - panobinostat" ] ] ], [ fhir:index 68 ; fhir:CodeSystem.concept.code [ fhir:value "L01XX05" ] ; fhir:CodeSystem.concept.display [ fhir:value "hydroxycarbamide" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XX05 - hydroxycarbamide" ] ], [ fhir:index 69 ; fhir:CodeSystem.concept.code [ fhir:value "L01XX35" ] ; fhir:CodeSystem.concept.display [ fhir:value "anagrelide" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XX35 - anagrelide" ] ], [ fhir:index 70 ; fhir:CodeSystem.concept.code [ fhir:value "L01XX52" ] ; fhir:CodeSystem.concept.display [ fhir:value "venetoclax" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L01XX52 - venetoclax" ] ], [ fhir:index 71 ; fhir:CodeSystem.concept.code [ fhir:value "L03AB" ] ; fhir:CodeSystem.concept.display [ fhir:value "Interferons" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L03AB - Interferons" ] ], [ fhir:index 72 ; fhir:CodeSystem.concept.code [ fhir:value "L04A" ] ; fhir:CodeSystem.concept.display [ fhir:value "IMMUNOSUPPRESSANTS" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L04A - IMMUNOSUPPRESSANTS" ] ; fhir:CodeSystem.concept.concept [ fhir:index 0 ; fhir:CodeSystem.concept.code [ fhir:value "L04AA" ] ; fhir:CodeSystem.concept.display [ fhir:value "Selective immunosuppressants" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L04AA - Selective immunosuppressants" ] ; fhir:CodeSystem.concept.concept [ fhir:index 0 ; fhir:CodeSystem.concept.code [ fhir:value "L04AA34" ] ; fhir:CodeSystem.concept.display [ fhir:value "alemtuzumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L04AA34 - alemtuzumab" ] ], [ fhir:index 1 ; fhir:CodeSystem.concept.code [ fhir:value "L04AA40" ] ; fhir:CodeSystem.concept.display [ fhir:value "cladribine" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L04AA40 - cladribine" ] ] ] ], [ fhir:index 73 ; fhir:CodeSystem.concept.code [ fhir:value "L04AD01" ] ; fhir:CodeSystem.concept.display [ fhir:value "ciclosporin" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L04AD01 - ciclosporin" ] ], [ fhir:index 74 ; fhir:CodeSystem.concept.code [ fhir:value "L04AX02" ] ; fhir:CodeSystem.concept.display [ fhir:value "thalidomide" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L04AX02 - thalidomide" ] ], [ fhir:index 75 ; fhir:CodeSystem.concept.code [ fhir:value "L04AX04" ] ; fhir:CodeSystem.concept.display [ fhir:value "lenalidomide" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L04AX04 - lenalidomide" ] ], [ fhir:index 76 ; fhir:CodeSystem.concept.code [ fhir:value "L04AX06" ] ; fhir:CodeSystem.concept.display [ fhir:value "pomalidomide" ] ; fhir:CodeSystem.concept.definition [ fhir:value "L04AX06 - pomalidomide" ] ], [ fhir:index 77 ; fhir:CodeSystem.concept.code [ fhir:value "M05BA03" ] ; fhir:CodeSystem.concept.display [ fhir:value "pamidronic acid" ] ; fhir:CodeSystem.concept.definition [ fhir:value "M05BA03 - pamidronic acid" ] ], [ fhir:index 78 ; fhir:CodeSystem.concept.code [ fhir:value "M05BA08" ] ; fhir:CodeSystem.concept.display [ fhir:value "zoledronic acid" ] ; fhir:CodeSystem.concept.definition [ fhir:value "M05BA08 - zoledronic acid" ] ], [ fhir:index 79 ; fhir:CodeSystem.concept.code [ fhir:value "M05BX04" ] ; fhir:CodeSystem.concept.display [ fhir:value "denosumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "M05BX04 - denosumab" ] ], [ fhir:index 80 ; fhir:CodeSystem.concept.code [ fhir:value "S01LA08" ] ; fhir:CodeSystem.concept.display [ fhir:value "bevacizumab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "S01LA08 - Bevacizumab" ] ], [ fhir:index 81 ; fhir:CodeSystem.concept.code [ fhir:value "V10X" ] ; fhir:CodeSystem.concept.display [ fhir:value "OTHER THERAPEUTIC RADIOPHARMACEUTICALS" ] ; fhir:CodeSystem.concept.definition [ fhir:value "V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS" ] ; fhir:CodeSystem.concept.concept [ fhir:index 0 ; fhir:CodeSystem.concept.code [ fhir:value "V10XA53" ] ; fhir:CodeSystem.concept.display [ fhir:value "tositumomab/iodine (131I) tositumomab" ] ; fhir:CodeSystem.concept.definition [ fhir:value "V10XA53 - tositumomab/iodine (131I) tositumomab" ] ], [ fhir:index 1 ; fhir:CodeSystem.concept.code [ fhir:value "V10XX02" ] ; fhir:CodeSystem.concept.display [ fhir:value "ibritumomab tiuxetan (90Y)" ] ; fhir:CodeSystem.concept.definition [ fhir:value "V10XX02 - ibritumomab tiuxetan (90Y)" ] ] ] . # - ontology header ------------------------------------------------------------ <http://hl7.org/fhir/CodeSystem/ATC.ttl> a owl:Ontology ; owl:imports fhir:fhir.ttl ; owl:versionIRI <http://build.fhir.org/CodeSystem/ATC.ttl> .
IG © 2022+ Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. Package dk.kip.rkkp.fhir.ig.core#2.23.2 based on FHIR 4.0.1. Generated 2026-07-03
Links: Table of Contents |
QA Report